| 1 |
35287352 | Analysis of the role and mechanism of EGCG in septic cardiomyopathy based on network pharmacology. | 2022 |
3 |
| 2 |
32817909 | ROS-responsive capsules engineered from EGCG-Zinc networks improve therapeutic angiogenesis in mouse limb ischemia. | 2021 Jan |
2 |
| 3 |
31743875 | Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1α/VEGF/VEGFR2 pathway and M1 type macrophage/microglia polarization. | 2020 Jan |
3 |
| 4 |
32354067 | Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization Via Inhibition of VEGF Production. | 2020 Apr 28 |
1 |
| 5 |
32475087 | Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulfate. | 2020 Jul |
2 |
| 6 |
30310905 | Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models. | 2018 Nov 14 |
2 |
| 7 |
28042007 | Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke. | 2017 Mar 15 |
1 |
| 8 |
25333353 | Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. | 2015 Jan |
1 |
| 9 |
25845434 | Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells. | 2015 Jun |
3 |
| 10 |
26516907 | Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells. | 2015 Oct 27 |
4 |
| 11 |
23292117 | (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. | 2013 Mar |
3 |
| 12 |
23638734 | EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression. | 2013 May 2 |
5 |
| 13 |
23725836 | Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2. | 2013 May |
2 |
| 14 |
24018658 | Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis. | 2013 |
2 |
| 15 |
21782236 | The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. | 2011 Oct |
1 |
| 16 |
21993466 | Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. | 2011 Dec |
1 |
| 17 |
22057492 | Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness. | 2011 Sep |
2 |
| 18 |
19088106 | Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. | 2009 Mar |
1 |
| 19 |
19145512 | [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism]. | 2009 Jan |
3 |
| 20 |
17981559 | EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. | 2008 Jan 1 |
1 |
| 21 |
18549879 | A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. | 2008 Jun |
2 |
| 22 |
17031857 | (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. | 2007 Apr 1 |
5 |